The Immunosuppressive Properties of the HIV Vpr Protein Are Linked to a Single Highly Conserved Residue, R90

• Irina Tcherepanova ,

  * E-mail: itcherepanova@argostherapeutics.com

  Affiliation Research and Development Department, Argos Therapeutics, Inc. Durham, North Carolina, United States of America

  ⨯
• Aijing Starr,

  Affiliation Duke Clinical Research Institute, Durham, North Carolina, United States of America

  ⨯
• Brad Lackford,

  Affiliation National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, United States of America

  ⨯
• Melissa D. Adams,

  Affiliation BD Diagnostics, Durham, North Carolina, United States of America

  ⨯
• Jean-Pierre Routy,

  Affiliation McGill University Health Center and INSERM Unit 743, Montréal, Canada

  ⨯
• Mohamed Rachid Boulassel,

  Affiliation McGill University Health Center and INSERM Unit 743, Montréal, Canada

  ⨯
• David Calderhead,

  Affiliation Research and Development Department, Argos Therapeutics, Inc. Durham, North Carolina, United States of America

  ⨯
• Don Healey,

  Affiliation Research and Development Department, Argos Therapeutics, Inc. Durham, North Carolina, United States of America

  ⨯
• Charles Nicolette

  Affiliation Research and Development Department, Argos Therapeutics, Inc. Durham, North Carolina, United States of America

  ⨯